Echo Therapeutics Inc  

(Public, OTCMKTS:ECTE)   Watch this stock  
Find more results for Alan Goldberg
1.10
+0.03 (2.80%)
Jul 26 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 1.10 - 1.12
52 week 0.88 - 2.84
Open 1.10
Vol / Avg. 7,126.00/88,414.00
Mkt cap 12.54M
P/E     -
Div/yield     -
EPS -1.48
Shares 11.40M
Beta 1.14
Inst. own 13%
Aug 12, 2016
Q2 2016 Echo Therapeutics Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 20, 2016
Q1 2016 Echo Therapeutics Inc Earnings Release
  

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -1173.85% -331.29%
Return on average equity - -645.26%
Employees 17 -
CDP Score - -

Address

99 Wood Ave S Ste 302
ISELIN, NJ 08830-2715
United States - Map
+1-732-5490919 (Phone)
+1-302-6365454 (Fax)

Website links

Description

Echo Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States.

Officers and directors

Scott W. Hollander President, Chief Executive Officer, Director
Age: 49
Alan W. Schoenbart CPA Chief Financial Officer, Secretary
Age: 56
Elazer R Edelman M.D., Ph.D. Director
Michael M. Goldberg M.D. Independent Director
Age: 56
Shepard M. Goldberg Independent Director
Age: 60